Celldex Therapeutics Inc (NASDAQ:CLDX)

25.54
Delayed Data
As of Feb 27
 +0.60 / +2.41%
Today’s Change
10.76
Today|||52-Week Range
31.88
+39.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues46.8M9.3M11.2M4.1M
 
 
 
 
 
Cost of Goods Sold39.7M6.9M8.7M2.3M
 
 
 
 
 
Depreciation And Amortization5.9M4.2M3.1M2.9M
 
 
 
 
 
 
Operating ExpensesGross Income1.2M-1.8M-663.0K-1.2M
 
 
 
 
 
General Expenses7.7M41.7M57.4M80.3M
 
 
 
 
 
Research And Development0.0032.4M47.4M65.5M
 
 
 
 
Total Operating Expenses53.3M52.7M69.3M85.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.5M-43.4M-58.1M-81.4M
 
 
 
 
 
Interest Expense On Debt1.3M1.8M1.6M927.0K
 
 
 
 
 
Other Expenses50.0K50.0K100.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.5M-44.8M-59.1M-81.6M
 
 
 
 
 
Net Income-2.5M-44.8M-59.1M-81.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS31.9M39.5M57.7M79.8M
 
 
 
 
 
Shares To Calculate EPS Diluted31.9M39.5M57.7M79.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.08-$1.13-$1.02-$1.02
 
 
 
 
 
EPS Diluted-$0.08-$1.13-$1.02-$1.02
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account